UNSPSC 41141901: 17-hydroxycorticosteroids (17-ketogenic steroids) test system

In this classification, 17-hydroxycorticosteroids (17-ketogenic steroids) test system connotes a device used to measure 17-hydroxycorticosteroids (17-ketogenic steroids) levels. US FDA regulates 17-hydroxycorticosteroids (17-ketogenic steroids) test system under 21 CFR 862.1385 and under FDA product code JHE.

UNSPSC 41141901 17-hydroxycorticosteroids (17-ketogenic steroids) test system is a Commodity code that in practice covers forensic drug analysis reagents, reference standards, and related laboratory testing equipment procured by state law enforcement and public health agencies. State and local governments buying under this code seek Direct ELISA testing kits for substance screening (cannabinoids, opiates, PCP, amphetamines, benzodiazepines, and related compounds), certified drug reference standards for method validation and evidentiary analysis, DNA screening kits for laboratory applications, and mass spectrometry equipment for chemical identification. The issuing bodies are primarily state departments of public safety and criminal justice, state health services agencies, county forensic laboratories, and state departments of financial and professional regulation acting on behalf of multi-jurisdictional government user bases. Solicitations are issued as IFBs, ITQs (Invitations to Quote), and notices of intent to award sole-source or proprietary procurements, reflecting both competitive and single-source purchasing strategies when equivalent products or authorized distributors are at issue.

Recent activity concentrates in Texas and Florida, with secondary representation from Illinois. The Texas Department of Public Safety posted IFB 405-26R0008445A on July 9, 2026, requesting immunalysis reagent kits (12 line items of Direct ELISA testing kits for drug substance analysis) with electronic bids due July 23, 2026. Pinellas County, Florida, in partnership with the Florida Department of Law Enforcement, issued Invitation to Quote 26-0305-ITQ on April 23, 2026, for 131 line items of certified drug reference standards meeting ISO/IEC 17025:2017 and ISO 17034:2016 accreditation standards, with Pinellas County Certified Small Business Enterprises receiving preference and a five percent price advantage above open market pricing. The Texas Health and Human Services Commission solicited QIAxcel and QIAamp DNA screening kits (IFB HHS0016902v2, due January 29, 2026) with historical annual spend between $25,050 and $30,000. The Illinois Department of Financial and Professional Regulation's Centralized Maintenance Services issued a notice of intent to sole-source mosquito testing equipment (RAMP System, West Nile Virus and Dengue test kits) to ADAPCO, LLC through a master contract supporting multiple government jurisdictions across the United States, with a public hearing scheduled for May 20, 2026.